Sanctioning the World Health Organization: A Familiar Pattern of Strategic Blinding
This analysis examines the U.S. approach to the WHO, specifically the threat or execution of funding cuts, through the lens of power and money networks. THE ACTORS: Who is involved in this story? The U.S. Executive Branch: Historically, both Republican and Democratic administrations have leveraged U.S. financial contributions to international organizations to exert influence. During the COVID-19
pandemic (2020-2022), the Trump administration explicitly moved to withdraw from the WHO, citing its alleged bias towards China. The Biden administration later reversed this decision but maintained stringent conditions for re-engagement. The U.S. Congress: Often plays a dual role, either aligning with executive branch pressure or providing a counter-narrative, particularly when domestic political
interests are at stake. Budgetary appropriations for international bodies are a key mechanism for this influence. The World Health Organization (WHO): An international body composed of 194 member states, primarily funded by assessed contributions from member states and voluntary contributions from both states and non-state actors. Its mandate is to promote health, keep the world safe, and serve
the vulnerable. Pharmaceutical Industry & Biosecurity Contractors: These private entities often lobby heavily in Washington, D.C., influencing policy discourse around global health and pandemic preparedness. Their financial interests frequently align with national security frameworks that favor specific research and development priorities. THE FUNDING: Where does their money come from? U.S.